Results 151 to 160 of about 3,814,825 (281)

Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review. [PDF]

BMJ Open
Flinkier A, Dewapura S, Tran H, Yin Z, Tran N, Berman J, Ratnasekara V, Raykateeraroj N, Fink M, Lee DK, Weinberg L.   +10 more
europepmc   +1 more source

Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis. [PDF]

Cells, 2022
Rovati G, Contursi A, Bruno A, Tacconelli S, Ballerini P, Patrignani P.   +5 more
europepmc   +1 more source

Improved prognosis prediction of all‐cause mortality and cardiovascular events by combined assessment of both ankle‐brachial index and brachial‐ankle pulse wave velocity in individuals with diabetes: The Kyushu prevention study for atherosclerosis, a prospective, multicenter survey

Journal of Diabetes Investigation, EarlyView.
A novel algorithm combining ABI and baPWV was developed to predict mortality and CVD risk in individuals with diabetes. This algorithm improved the accuracy of mortality and CVD risk assessment and was independent from the Framingham Risk Score. ABSTRACT Aims/Introduction People with diabetes exhibit early‐stage cardiovascular disease (CVD).
Erina Eto, Yasutaka Maeda, Noriyuki Sonoda, Hajime Nawata, Ryoichi Takayanagi, Michio Shimabukuro, Toyoshi Inoguchi   +6 more
wiley   +1 more source

A cecal slurry mouse model of polymicrobial abdominal sepsis to evaluate the effects of antiplatelet agents. [PDF]

Res Pract Thromb Haemost
Mansour A, Gouin-Thibault I, Rossi E, Marchelli A, Belleville-Rolland T, Nesseler N, Gaussem P, Bachelot-Loza C.   +7 more
europepmc   +1 more source

Sodium–glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial

Journal of Diabetes Investigation, EarlyView.
Combining oral sodium‐glucose cotransporter 2 inhibitors with reduced intravitreal injections of anti‐vascular endothelial growth factor showed potential efficacy for mild diabetic macular edema. ABSTRACT Aims To investigate the potential of sodium–glucose cotransporter 2 inhibitors (SGLT2i) as a less invasive treatment option for mild diabetic macular
Yoko Takatsuna, Ryoichi Ishibashi, Masaya Koshizaka, Tomoaki Tatsumi, Takayuki Baba, Shuichi Yamamoto, Koutaro Yokote   +6 more
wiley   +1 more source

Piperazine-Thiourea Hybrids as Novel Antiplatelet Agents Targeting COX-1: Synthesis, <i>in Vitro</i>, and <i>in Silico</i> Evaluation. [PDF]

ACS Omega
Pereira GRC, Viana GM, Huber MB, Rodrigues PS, Gonçalves ARSP, Sathler PC, Rodrigues CR, Abrahim-Vieira BA, Cabral LM.   +8 more
europepmc   +1 more source

Factfinders for patient safety: Anticoagulant and antiplatelet agents and cervical medial branch procedures. [PDF]

Interv Pain Med, 2022
Lee H, Saffarian M, Babaria V, McCormick ZL, Spine Intervention Society's Patient Safety Committee.   +4 more
europepmc   +1 more source

Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.

Blood, 2018
X. Xu, G. Yousef, H. Ni
semanticscholar   +1 more source

Primary cardiovascular preventive effect of thiazolidinedione in adults with type 2 diabetes: A nationwide cohort study in Korea

Journal of Diabetes Investigation, EarlyView.
Among Korean adults with type 2 diabetes and no prior cardiovascular disease, thiazolidinedione use was associated with a lower risk of the primary composite outcome of stroke, myocardial infarction, hospitalization for heart failure, and all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitor use. ABSTRACT Background Thiazolidinediones (TZDs)
Yun Young Choi, Jimin Jeon, Minyoul Baik, Joonsang Yoo, Jinkwon Kim   +4 more
wiley   +1 more source

Tongue laceration in a patient taking antiplatelet agents during transcranial motor-evoked potential monitoring: a case report. [PDF]

JA Clin Rep, 2022
Matsumoto K, Nakagawa H, Kitamura A.
europepmc   +1 more source